Most microbes live in the colon
A few microbes normally live in the small intestine; the largest community is farther downstream in the colon.
Visual field guide 01Small intestine
SIBO isn’t simply “too many bacteria.” It’s microbes and their activity in the wrong place—turning food into gas before your body is finished absorbing it.
See what’s happening ↘A calm, 4-minute visual tour
01 — WHAT’S HAPPENING
Your gut is a long ecosystem. Location changes everything.
This is fermentation. Microbes break down available carbohydrates and use them as fuel. Gas is one of the by-products.
A few microbes normally live in the small intestine; the largest community is farther downstream in the colon.
Before food arrives, a larger or altered microbial population is established too far upstream in the small intestine.
The small intestine normally contains bacteria, and many gut microbes are useful. SIBO describes too many bacteria—or an altered mix and activity—in the small bowel. The problem is the ecosystem, amount and location, not that every bacterium shown is harmful.
The symptom pattern depends on gas pressure, fluid movement, methane production and how much nutrient absorption is affected.
Gas can stretch the intestinal wall and create pressure.
Unabsorbed carbohydrates can keep extra water inside the bowel.
Methane-producing archaea are associated with slower intestinal transit.
Persistent, significant overgrowth can interfere with nutrient absorption.
02 — HOW THE CONDITIONS DEVELOP
It usually starts when the small intestine cannot clear microbes normally, or when its structure creates a place for them to linger.
Between meals, coordinated contractions help sweep residue and microbes forward. Motility disorders, diabetes and some neurological or connective-tissue conditions can weaken that clearance.
Prior surgery, strictures, diverticula or blind loops can create areas of stasis—places where contents move slowly and microbes have more time to multiply.
Opioids and some other medicines can slow intestinal movement. Acid-suppressing treatment is also associated with SIBO in some studies, although cause and effect are not always clear.
Antimicrobials may reduce the overgrowth, but recurrence is more likely when constipation, impaired motility or a structural problem is still present.
03 — WHY FOOD CAN TRIGGER SYMPTOMS
Food doesn’t “cause” SIBO. But poorly absorbed carbohydrates can become fuel for fermentation—and symptoms.
Choose a food
Fructans
Relative tendencies, not clinical scores. Dose, absorption and individual response can change the result.
Fructans can escape absorption and become quick fuel for gut microbes.
Poorly absorbed carbohydrates remain as dissolved particles inside the intestine.
→Water follows that concentration gradient by osmosis, so more fluid stays in the bowel.
→Possible result: softer stool, urgency or diarrhoea. The colon may reabsorb some of that water, so the effect varies.
A symptom after food is a clue, not a diagnosis. Tolerance depends on dose, gut movement, sensitivity, and the rest of the meal.
Choose a claim to see what the gut actually does—and the practical rule worth keeping.
“Water with a meal dilutes stomach acid and causes SIBO.”MOSTLY MYTH
There is no clinical evidence that normal water intake with meals causes SIBO or switches digestion off. Small physiology studies have not found impaired gastric emptying from water with a meal; carbonation may increase belching.
Drink normally for thirst and comfort. Reduce very large drinks only if they worsen fullness or reflux, and limit fizzy drinks or straws if they add belching.
04 — HOW BREATH TESTING WORKS
Your cells don’t make hydrogen or methane. If those gases rise after a test sugar, microbes made them—and some enter your bloodstream, lungs, then breath.
Usually glucose or lactulose, after careful preparation and fasting.
Blow into tubes at timed intervals, commonly over 2–3 hours.
The lab measures hydrogen and methane in parts per million.
Example breath trace
Pattern clueOften associated with diarrhoea or faster transit
Preparation, transit speed, the chosen sugar and the lab protocol can affect results. Interpretation should combine the curve with symptoms and clinical context.
Proximal SIBO is nearer the stomach, in the duodenum or jejunum. Distal SIBO is farther along, mainly in the ileum near the colon. Overgrowth may also be patchy or extend across both.
Hydrogen is bacterial SIBO. Methane-positive results are called IMO because archaea—not bacteria—can overgrow anywhere in the intestine. Hydrogen-sulfide or ISO is an emerging category with less-settled testing standards.
Glucose is absorbed early, so it is better at seeing proximal activity and may miss distal overgrowth. Lactulose travels farther, but rapid transit into the colon can imitate an early positive. A breath test cannot precisely map the location.
05 — HOW TREATMENT WORKS
Treatment is not one magic “kill phase.” The durable plan addresses both microbial activity and why the small intestine became vulnerable.
Symptoms, history and testing help distinguish SIBO/IMO from look-alikes.
DIAGNOSISClinician-directed antibiotics are the usual evidence-based treatment.
TARGETAddress constipation, anatomy, medicines or disorders that slow clearance.
PREVENTUse diet for short-term symptom control, then widen it with expert guidance.
RECOVERRifaximin is poorly absorbed, so most of its action stays inside the intestinal lumen. It is commonly prescribed for SIBO, often off-label depending on the country and indication. It can reduce bacterial activity, but it does not correct the motility or structural reason the overgrowth developed.
A 2025 open-label, single-centre randomised trial abstract reported that berberine was non-inferior to rifaximin for breath-test conversion and symptom outcomes in 186 completers.
Oregano, thyme, neem and allicin protocols still lean heavily on a 2014 retrospective chart review in which patients chose herbal treatment or rifaximin.
That makes berberine scientifically interesting—not a proven interchangeable substitute. The randomised result is currently a conference abstract, products vary, and independent replication with full safety reporting is still needed.
Methane is produced by archaea rather than bacteria, so clinicians may use a different or combined treatment strategy. Do not copy an antibiotic regimen from a hydrogen-positive case.
A temporary lower-fermentation or low-FODMAP approach may reduce symptoms, but it does not prove or eradicate SIBO. Restriction should be time-limited and followed by structured reintroduction.
Recurrence is more likely if impaired motility, constipation, altered anatomy or another underlying condition remains. This is the part a personalised plan should investigate.
06 — WHEN SIBO PERSISTS
Not every positive test leads to lasting harm. Risk depends on severity, duration and the underlying cause. The clearest concerns are persistent gut symptoms and, in more significant cases, poor nutrient absorption.
Bloating, pain, diarrhoea or constipation may persist and make eating, sleep and day-to-day life harder.
Microbes compete for nutrients and can interfere with fat absorption. Deficiencies—especially vitamin B12 and fat-soluble vitamins—can develop in more severe cases.
Reduced absorption, diarrhoea and eating less to avoid symptoms can combine. Marked weight loss is not typical of a mild case and needs medical assessment.
An untreated motility, anatomical or medical problem can allow overgrowth to return even after microbes are reduced.
The strongest evidence is nutritional. These effects come from reduced intake or absorption—not from gas travelling around the body—and are more likely in persistent or severe SIBO.
Early fullness, nausea or fear of symptoms can reduce food intake. At the same time, diarrhoea and impaired carbohydrate, fat or protein absorption can reduce the calories the body retains.
AGA clinical update ↗Overgrown bacteria can use vitamin B12 or convert it to inactive analogues before it is absorbed in the ileum. Deficiency may cause megaloblastic anaemia, fatigue, numbness, tingling or balance problems.
B12 absorption study ↗Bacterial enzymes can deconjugate bile salts, weakening the micelles needed to absorb fat. Prolonged fat malabsorption can reduce vitamins A, D and E; reported consequences include bone disease or neuropathy.
Human bile-acid study ↗07 — KEEP READING
A starting library of guidelines, peer-reviewed papers and practical books. Research evolves, so the live searches matter as much as the fixed list.
Dr Mark Pimentel & Dr Ali Rezaie
Find on Amazon AU ↗Dr William Davis
Find on Amazon AU ↗Dr Sue Shepherd & Dr Peter Gibson
Find on Amazon AU ↗Kate Scarlata & Dédé Wilson
Find on Amazon AU ↗THE WHOLE STORY, IN ONE LINE